肌肉与肝脏胰岛素抵抗关联不同的血浆蛋白谱:DiOGenes试验数据
该研究基于DiOGenes队列(n=535)中超重或肥胖个体,分析肌肉胰岛素抵抗(IR)与肝脏IR各自相关的血浆蛋白及通路。肌肉IR关联160种蛋白,肝脏IR关联81种,仅12种共享;肌肉IR富集51条通路(强烈的炎症特征,包括趋化因子、IL-6及补体信号),肝脏IR富集11条通路(主要与补体系统相关)。
要点
- 肌肉IR与160种蛋白相关,肝脏IR与81种相关,仅12种重叠。
- 肌肉IR富集51条通路,以炎症(趋化因子、IL-6、补体)为特征。
- 肝脏IR富集11条通路,主要涉及补体系统。
核心结论
- 肌肉IR与肝脏IR具有不同的血浆蛋白谱和通路特征,肌肉IR炎症特征更强。
- 理解不同IR表型的机制可能有助于制定个性化预防策略。
研究设计与样本
- 基于DiOGenes队列(n=535)中超重或肥胖个体的横断面分析。
- 校正研究中心、性别、BMI和年龄,肝脏IR与肌肉IR相互校正。
- 对差异丰度蛋白进行通路富集分析。
主要发现
- 肌肉IR关联160种蛋白,肝脏IR关联81种,其中12种为两者共享。
- 肌肉IR富集51条通路,包括趋化因子信号、白细胞介素-6信号和补体系统相关通路。
- 肝脏IR富集11条通路,主要与补体系统相关。
临床怎么用
- 提示肌肉IR与肝脏IR的病理机制不同,未来可据此探索表型特异的预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Insulin resistance (IR) can develop in multiple organs, representing distinct etiologies toward cardiometabolic disease. OBJECTIVE: This study aimed to investigate which proteins and pathways are specific for liver IR or muscle IR in individuals with overweight or obesity of the Diet, Obesity, and Genes cohort (n = 535) (NCT00390637, ClinicalTrials.gov). METHODS: First, independent associations between muscle and liver IR and protein abundance levels were assessed. In the analysis, we corrected for study center, sex, body mass index, and age, whereby the analyses on liver IR were adjusted for muscle IR and vice versa. Differentially abundant proteins were then subjected to pathway enrichment analysis. RESULTS: Muscle IR was associated with 160 proteins, and liver IR was associated with 81 proteins. Of these, 12 were shared between both forms of IR. Pathway enrichment analysis identified 51 enriched pathways for muscle IR, characterized by a strong inflammatory profile, including chemokine signaling, interleukin-6 signaling, and complement system-related pathways. In contrast, liver IR was associated with 11 enriched pathways, primarily related to the complement system. CONCLUSION: Understanding the processes underlying these distinct IR phenotypes could inform the development of personalized prevention strategies.
引用
- Kemper EJ, Blaak EE, Adriaens ME, et al. Muscle and Liver Insulin Resistance Are Associated with Distinct Plasma Protein Profiles: Data from the DiOGenes Trial. J Clin Endocrinol Metab. 2026. PMID: 41068881. doi:10.1210/clinem/dgaf562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。